MPO and systemic lupus erythematosus: Additionally, plasma MPO levels and MPO oxidation products are elevated in patients in autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, both of which carry an increased risk of CVD (55, 56).